Content Library
Speaker Interview With:
Timothy Yap, Associate Professor, Investigational Cancer Therapeutics, MD Anderson Cancer Center
The Potential of PARP & ATR Inhibitor Combinations
Past Presentation From:
Kirk Tanner, Chief Scientific Officer, National Brain Tumor Society
Ranjit Bindra, Professor and Vice-Chair for Translational Research, Departments of Therapeutic Radiology and Pathology, Yale School of Medicine and Scientific Director, Brain Tumor Center, Yale Cancer Center
Penetrating the Brain Tumor Space with DDR Inhibitors
Past Presentation From:
Nicola Curtin, Professor of Experimental Cancer Therapeutics, Newcastle University